Zynex eyes FDA submission for NiCO pulse oximeter following successful verification trialProactive Investors • 12/05/24
Zynex joins Open Oximetry Project as it advances innovative NiCO pulse oximeterProactive Investors • 12/03/24
Zynex leverages multi-modality NexWave device to transform pain managementProactive Investors • 11/26/24
Zynex sees pain management orders increase in Q3 following FDA approvalProactive Investors • 10/24/24
Sales, strategy, and saving lives: A conversation with Zynex CEO Thomas SandgaardProactive Investors • 10/24/24
Zynex Stock Rises on FDA Clearance of Its New Pain Management DeviceZacks Investment Research • 09/04/24
Zynex's bold expansion in patient monitoring technologies moves from vision to realityProactive Investors • 08/20/24
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market SessionBenzinga • 07/26/24